Healthcare -
Biotechnology - NASDAQ - US
$ 36.91
0.819 %
$ 3.49 B
Market Cap
-6.33
P/E
RARE - OPERATING INCOME
Operating Income RARE - Ultragenyx Pharmaceutical Inc.
-536 M
LAST VALUE
9.12%
2 YEAR CAGR
-4.79%
5 YEAR CAGR
-25.17%
10 YEAR CAGR